These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35830185)

  • 1. CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease.
    Lu L; Mao H; Zhou M; Lin Y; Dai W; Qiu J; Xiao Y; Mo M; Zhu X; Wu Z; Pei Z; Guo W; Xu P; Chen X
    Chin Med J (Engl); 2022 Jul; 135(13):1588-96. PubMed ID: 35830185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
    Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
    Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in
    Chen X; Lin Y; Zhang Z; Tang Y; Ye P; Dai W; Zhang W; Liu H; Peng G; Huang S; Qiu J; Guo W; Zhu X; Wu Z; Kuang Y; Xu P; Zhou M
    Neural Regen Res; 2024 Jan; 19(1):196-204. PubMed ID: 37488867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of CHCHD2 may Contribute to Parkinson's Disease by Reducing Expression of NFE2L2 and RQCD1.
    Li K; Ning P; Liu B; Yang H; Zhu Y; Yin W; Zhou C; Ren H; Yang X
    Curr Neurovasc Res; 2022; 19(1):19-29. PubMed ID: 35388756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.
    Zhou W; Ma D; Tan EK
    Neuroscientist; 2020 Apr; 26(2):170-184. PubMed ID: 31526091
    [No Abstract]   [Full Text] [Related]  

  • 6. CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
    Mao C; Wang H; Luo H; Zhang S; Xu H; Zhang S; Rosenblum J; Wang Z; Zhang Q; Tang M; Shepard MJ; Wang X; Wang Y; Zhuang Z; Shi C; Xu Y
    Neurobiol Aging; 2019 Mar; 75():38-41. PubMed ID: 30530185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
    Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
    Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
    Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
    Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.
    Kee TR; Espinoza Gonzalez P; Wehinger JL; Bukhari MZ; Ermekbaeva A; Sista A; Kotsiviras P; Liu T; Kang DE; Woo JA
    Front Aging Neurosci; 2021; 13():660843. PubMed ID: 33967741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson's disease phenotypes in vivo and in cell models.
    Tio M; Wen R; Choo CN; Tan JB; Chua A; Xiao B; Sundaram JR; Chan CHS; Tan EK
    J Biomed Sci; 2024 Feb; 31(1):24. PubMed ID: 38395904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
    Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
    Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of CHCHD2 mutations in Parkinson's disease in a Taiwanese population.
    Fan TS; Lin HI; Lin CH; Wu RM
    Neurobiol Aging; 2016 Feb; 38():218.e1-218.e2. PubMed ID: 26725463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.
    Ren YL; Jiang Z; Wang JY; He Q; Li SX; Gu XJ; Qi YR; Zhang M; Yang WJ; Cao B; Li JY; Wang Y; Chen YP
    Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38453793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Imai Y; Meng H; Shiba-Fukushima K; Hattori N
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Aminoethoxydiphenyl borate ameliorates mitochondrial dysfunctions in MPTP/MPP
    Vaidya B; Polepalli M; Sharma SS; Singh JN
    Mitochondrion; 2023 Mar; 69():95-103. PubMed ID: 36758857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse midbrain dopaminergic neurons survive loss of the PD-associated mitochondrial protein CHCHD2.
    Nguyen MK; McAvoy K; Liao SC; Doric Z; Lo I; Li H; Manfredi G; Nakamura K
    Hum Mol Genet; 2022 May; 31(9):1500-1518. PubMed ID: 34791217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
    Straub IR; Janer A; Weraarpachai W; Zinman L; Robertson J; Rogaeva E; Shoubridge EA
    Hum Mol Genet; 2018 Jan; 27(1):178-189. PubMed ID: 29121267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases.
    Zhou ZD; Saw WT; Tan EK
    Mol Neurobiol; 2017 Sep; 54(7):5534-5546. PubMed ID: 27631878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
    Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
    EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in CHCHD2 cause α-synuclein aggregation.
    Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
    Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.